Characterization of the Cellular Reaction to a Collagen-Based Matrix: An In Vivo Histological and Histomorphometrical

Samuel Ebele Udeabor1,2, Carlos Herrera-Vizcaíno1, Robert Sader1

  • 1Department for Oral, Cranio-Maxillofacial, and Facial Plastic Surgery, Frankfurt Orofacial Regenerative Medicine (FORM) Lab, Johann Wolfgang Goethe University, 60590 Frankfurt am Main, Germany.

Insights

Mucomaix matrix (MM) shows high permeability and fast degradation. It absorbed liquid platelet-rich fibrin (PRF) ex vivo and induced mild inflammation, progressing to multinucleated giant cells and vascularization in vivo.

Area of Science:

  • Biomaterials Science
  • Tissue Engineering
  • Inflammatory Response

Background:

  • Non-cross-linked collagen-based matrices are utilized in regenerative medicine.
  • Understanding the interaction between biomaterials and biological systems is crucial for clinical application.
  • Platelet-rich fibrin (PRF) is a blood concentrate with regenerative potential.

Purpose of the Study:

  • To evaluate the permeability and inflammatory tissue reaction to Mucomaix matrix (MM).
  • To assess the ex vivo interaction of MM with liquid PRF.
  • To analyze the in vivo host response to subcutaneously implanted MM in rats.

Main Methods:

  • Ex vivo absorption of liquid PRF by MM.
  • In vivo subcutaneous implantation of MM in Wistar rats (n=12) with a sham-operated control group (n=12).
  • Explantation at 3, 15, and 30 days for histological analysis and statistical evaluation (ANOVA, Tukey tests).

Main Results:

  • MM absorbed liquid PRF ex vivo.
  • Day 3: Mild inflammation with mononuclear cells (macrophages) at the implantation site.
  • Day 15-30: Increased multinucleated giant cells (MNGCs) associated with vascularization; significant matrix degradation observed.
  • Matrix core visible up to day 30.

Conclusions:

  • Mucomaix matrix exhibits high permeability and rapid degradation.
  • The in vivo response involves initial macrophage infiltration followed by MNGCs and vascularization.
  • MM demonstrates biocompatibility with controlled degradation and host tissue integration.